Wenhu Liu | Pharmacology | Excellence in Research

Posted on by sciencefather

Prof. Wenhu Liu | Pharmacology | Excellence in Research 

Prof. Wenhu Liu, at North Sichuan Medical College, China.

Wenhu Liu, born in February 1980, is a dedicated professor and researcher in the field of cancer pharmacology. He currently serves as the Director of the Medicinal Chemistry Teaching and Research Section at the School of Pharmacy, North Sichuan Medical College. A proud member of the Communist Party of China, Liu has made significant strides in understanding cancer pharmacology, particularly focusing on drug resistance mechanisms. His career reflects a balance of academic rigor, international exposure, and innovation-driven research. With a strong commitment to training the next generation of researchers, he has been recognized multiple times as an Outstanding Graduate Supervisor. Wenhu Liu’s contributions to both education and cancer pharmacology highlight his dedication to advancing the field, while also fostering an environment of collaboration and innovation. He remains committed to addressing the challenges of cancer treatment through his in-depth scientific explorations and academic mentorship.

Professional Profile

Scopus

🎓 Education

Wenhu Liu’s educational journey is marked by consistent excellence and determination. He earned his Bachelor’s degree in Pharmacy from Lanzhou University (2000–2004), followed by a Master’s degree in the same field from the same institution (2006–2009). Seeking to deepen his expertise, he pursued a Ph.D. at the School of Pharmacy, Chongqing University (2014–2017), where he was recognized as an outstanding student. His academic path reflects a steadfast commitment to pharmacology and cancer research. Liu’s focus on advanced studies laid the foundation for his current research in cancer drug resistance. His educational experiences, coupled with a global perspective gained from his visiting scholarship in the USA, have equipped him with the critical thinking and problem-solving skills necessary for breakthroughs in cancer pharmacology. Liu’s dedication to lifelong learning and knowledge-sharing is evident in his mentorship and teaching roles, shaping the next generation of scientists.

💼 Experience

Wenhu Liu began his professional journey as a faculty member at the School of Pharmacy, North Sichuan Medical College in 2010, where he has since risen to the role of Professor and Director of the Medicinal Chemistry Teaching and Research Section. His academic career has been marked by continuous learning and global exposure, including a visiting scholarship at the University of Toledo, USA (2013). Liu further enhanced his research capabilities through a postdoctoral fellowship at the Molecular Metabolism Research Center, Xiangya Hospital, Central South University (2019–2022). His extensive experience includes pioneering work on cancer drug resistance and metabolic signaling pathways, resulting in multiple publications and research grants. As a leader, Wenhu Liu fosters an environment of innovation and excellence, guiding students and colleagues alike. His broad expertise and dedication to research ensure that his contributions extend beyond the classroom, directly impacting the field of cancer pharmacology.

🔬 Research Interests

Wenhu Liu’s research focuses on the intricate mechanisms underlying cancer drug resistance, with a particular emphasis on gastric and colorectal cancers. His work delves into the signaling pathways that drive resistance to drugs like trastuzumab and oxaliplatin, aiming to overcome these hurdles in cancer therapy. Projects such as the investigation of HES1-mediated regulation via the TP53/SLC7A11/GPX4 axis and the RUNX3/E2F1/CHK1 signaling pathway highlight his commitment to unraveling these complex biological processes. Liu also explores the potential of natural compounds, like Panax Notoginseng saponins, in metabolic regulation and cancer treatment. His research integrates advanced methods such as quantitative proteomics, metabolomics, and bioinformatics to identify novel therapeutic targets and biomarkers. Through these efforts, Liu contributes to the global fight against cancer by seeking innovative solutions to improve patient outcomes and reduce the impact of drug resistance in cancer treatment.

🏆 Awards 

Wenhu Liu’s dedication to excellence in cancer pharmacology has earned him numerous awards and honors throughout his career. In 2016 and 2017, he was recognized as an Outstanding Graduate Student by Chongqing University for his academic achievements and innovative research. His commitment to mentorship and nurturing young scientists has been celebrated with the Outstanding Graduate Supervisor award by the School of Pharmacy, North Sichuan Medical College in both 2023 and 2024. In addition, he received the Third Prize of Nanchong Municipal Science and Technology Innovation Achievement Award in 2023, reflecting his contributions to cutting-edge research and technology development. That same year, Liu’s collaborative efforts were further acknowledged with the Nanchong Top Ten Innovative Team Achievement Award. These accolades underscore Liu’s passion for discovery, mentorship, and impact, cementing his reputation as a leader and role model in cancer pharmacology research and education.

📚Top Noted Publications

Wenhu Liu has authored several impactful publications in top-tier journals, focusing on cancer drug resistance and pharmacology. His recent work includes:

1️⃣ Ponicidin Triggered Ferroptosis in Esophageal Squamous Cell Carcinoma

  • Journal: Phytomedicine

  • Year: 2025 (In press)

  • Impact Factor: 6.7

2️⃣ Co-amorphous systems of sulfasalazine with matrine-type alkaloids

  • Journal: European Journal of Pharmaceutics and Biopharmaceutics

  • Year: 2024

  • Volume: 203

  • Article Number: 114475

  • Impact Factor: 4.4

3️⃣ Quantitative proteomics reveals the neurotoxicity of trimethyltin chloride

  • Journal: Neurotoxicology

  • Year: 2023

  • Volume: 99

  • Pages: 162–176

  • Impact Factor: 3.4

4️⃣ Serum proteomics unveil characteristic protein biomarkers

  • Journal: Clinical Proteomics

  • Year: 2022

  • Volume: 19

  • Article Number: 18

  • Impact Factor: 5.0

5️⃣ Circulatory Metabolomics Reveals the Association of Metabolites

  • Journal: Frontiers in Physiology

  • Year: 2022

  • Impact Factor: 4.0

6️⃣ Metabolic pathways underlying GATA6 regulation

  • Journal: International Journal of Medical Sciences

  • Year: 2020

  • Volume: 17

  • Issue: 18

  • Pages: 3146–3164

  • Impact Factor: 3.7

7️⃣ Label-free quantitative proteomics

  • Journal: Chinese Journal of Analytical Chemistry

  • Year: 2020

  • Volume: 48

  • Issue: 2

  • Pages: 187–196

  • Impact Factor: 1.2

Conclusion

Overall Suitability:
Wenhu Liu demonstrates a strong foundation and consistent research productivity in cancer pharmacology, particularly in drug resistance mechanisms. His role as a director and his awards for mentorship indicate strong leadership. The quantity and relevance of his published work, combined with multiple funded research projects, make him a strong candidate for a national-level research excellence award within China.

Charbel Fadel | Pharmacology | Best Researcher Award

Posted on by sciencefather

Charbel Fadel | Pharmacology | Best Researcher Award

Dr. Charbel Fadel, University of Pisa, Italy

Dr. Charbel Fadel is a renowned researcher in Veterinary Pharmacology with a PhD from the University of Sassari, Italy. He specializes in pharmacotherapy, quality control, and pharmacokinetics. Currently, Dr. Fadel is a Research Fellow at the University of Pisa, Italy, overseeing pharmacology lab operations and conducting animal studies. With a rich background in veterinary medicine, he has contributed to numerous scientific publications and presented at prestigious international conferences. Dr. Fadel’s work is focused on drug disposition, antimicrobial resistance, and improving veterinary pharmacology practices globally. He holds multiple honors and continues to impact veterinary science.

Publication Profile

Scopus

Education

Dr. Charbel Fadel is a distinguished veterinarian with extensive academic qualifications. He earned his Ph.D. in Veterinary Pharmacology, Pharmacotherapy, and Quality Control from the University of Sassari, Italy, in October 2023. Prior to this, he completed a Master’s degree in Veterinary Medicine, specializing in Small Animals’ Medicine, at L’Université Libanaise, Lebanon, in October 2020. His expertise in veterinary pharmacology and small animal care, combined with a passion for enhancing animal health, defines his professional journey.

Experience

Dr. Charbel Fadel has a rich professional background in veterinary medicine. Currently, he serves as a Research Fellow in Veterinary Pharmacology at the University of Pisa, Italy, where he oversees lab operations, manages pharmacokinetic studies, and collaborates with international teams to refine pharmacotherapy strategies. Before this, he was the Project and Operations Manager at IVet Medical in Beirut, Lebanon. In this role, he provided expert guidance to veterinarians on the use of biomedical machines, biological tests, and surgical instruments, while also managing the procurement and evaluation of medical supplies.

Awards

Dr. Charbel Fadel has earned numerous honors throughout his career. He has been an active reviewer for the Journal of Veterinary Pharmacology and Therapeutics since 2023 and was awarded the “Cultore della Materia” honor by the University of Pisa in January 2024 for his work as a Subject Specialist/Adjunct Lecturer. He received second runner-up for the 2023 JVPT Paper Award from Wiley Publishers, and his article on robenacoxib pharmacokinetics was recognized as the most cited in 2022-2023. Dr. Fadel also contributed to the “Rocinate Program” and completed several veterinary training programs in Russia.

Research Focus

Dr. Charbel Fadel’s research focus lies in veterinary pharmacology, particularly in the comparative pharmacokinetics of various drugs in livestock species like sheep and goats. His studies, including those on metronidazole and omeprazole, aim to enhance the understanding of drug absorption, distribution, metabolism, and excretion in these animals. This research is crucial for optimizing veterinary care and ensuring effective medication dosages in different animal species. Dr. Fadel’s work supports the development of more tailored and efficient treatment protocols for livestock, contributing to both animal health and agricultural practices.

Publication Top Notes

Comparative pharmacokinetic evaluation of metronidazole in sheep and goats

Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats

yang huanzhi | Pharmacology | Best Researcher Award

Posted on by sciencefather

yang huanzhi | Pharmacology | Best Researcher Award

Dr. yang huanzhi, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China, China

Dr. Huanzhi Yang is a Ph.D. candidate in Food Science and Engineering at China Agricultural University (2019–2025) 🎓, focusing on food nutrition, natural products, and chronic disease prevention. With a strong academic background from Hunan Agricultural University and Huaihua University, his research spans functional food development, gut health, and antioxidants. He has authored multiple high-impact publications 📝, holds several international patents 🧪, and has collaborated on national food science projects. Recognized for his innovation and excellence, Dr. Yang has received numerous scholarships, awards, and honors 🏆, showcasing his commitment to scientific advancement and food health solutions.

Publication Profile

Scopus

Education

Dr. Yang Huanzhi 🎓 is currently pursuing a Ph.D. in Engineering at China Agricultural University (2019.09–2025.06), specializing in Food Science and Engineering under the guidance of Prof. Xiaojun Liao 🍎. He earned his Master’s degree in Bioengineering from Hunan Agricultural University (2016.09–2018.06), mentored by Prof. Guoping Peng 🧬. Dr. Yang began his academic journey at Huaihua University, where he completed his Bachelor’s degree in Bioengineering (2012.09–2016.06) 📘. With a solid foundation in food and biosciences, his research focuses on advancing food science and nutritional engineering for a healthier future 🌱.

Experience

Dr. Yang Huanzhi’s research focuses on food nutrition and health 🍽️, emphasizing the role of natural products in preventing and controlling chronic diseases 💊. With a passion for improving public well-being, he explores the bioactive components in natural sources 🌿 and their potential in promoting long-term health. His work contributes to the development of functional foods that not only nourish but also serve therapeutic purposes 🥦. By integrating nutritional science with innovative food engineering, Dr. Yang aims to create sustainable, health-promoting dietary solutions for modern lifestyles 🧠❤️. His dedication is shaping the future of preventive nutrition and wellness.

Awards

Dr. Yang Huanzhi has been recognized for his outstanding academic and research achievements 🌟. From 2020 to 2024, he consistently received the “Second Class Scholarship” 🏅 for five consecutive years during his doctoral studies at China Agricultural University. In 2022, he earned the second prize in the 3rd “Xingnong Cup” Innovation and Entrepreneurship Competition 💡. His dedication to safety and responsibility earned him the honorary title of Excellent Laboratory Safety Officer for two consecutive years (2021–2022) 🧪🛡️. Additionally, in 2019, his master’s work was honored with the “Excellent Master’s Thesis” award from Hunan Agricultural University 📜🏆.

Research Focus

Dr. Yang Huanzhi focuses on nutraceuticals, gut microbiota, and inflammation-related diseases. His research delves into how natural plant-based compounds—particularly polyphenols from CiLi (Rosa roxburghii Tratt.)—can modulate the gut microbiota-lipid mediator-immunity axis to alleviate chronic inflammatory conditions such as colitis. 🌿 His work bridges phytochemistry, immunology, and microbiome research, emphasizing the therapeutic potential of functional foods and dietary interventions. 🧫💊 By uncovering the molecular pathways through which CiLi polyphenols influence gut health and immune regulation, Dr. Huanzhi contributes to the advancement of integrative medicine and functional nutrition in disease prevention and treatment.

Publication Top Notes

CiLi (Rosa roxburghii Tratt.) polyphenols improve colitis via gut microbiota-lipid mediator-immunity axis

Dan Yan | Pharmacology | Best Researcher Award

Posted on by sciencefather

Dan Yan | Pharmacology | Best Researcher Award

Prof. Dan Yan, Beijing Friendship Hospital, Capital Medical University, China China

Prof. Dan Yan is the Director of the Pharmacy Department and Vice Director of the Drug Clinical Trial Institution at Beijing Friendship Hospital, Capital Medical University. A leading expert in intelligent molecular diagnosis and combination therapies for chronic metabolic diseases, he has authored numerous high-impact publications and led national research projects. With a Ph.D. from Chengdu University of Traditional Chinese Medicine and postdoctoral training in cell biology, Prof. Yan also serves on key national academic committees. He work bridges traditional Chinese medicine with modern pharmacology to advance precision healthcare.

Publication Profile

Scopus

Education

Prof. Dan Yan 🎓 has dedicated he academic journey to the field of Traditional Chinese Medicine. He earned he Ph.D. (2004–2007), M.S. (2001–2004), and B.S. (1994–1998) degrees—all from the esteemed Chengdu University of Traditional Chinese Medicine 🏛️. He consistent pursuit of knowledge over the years reflects a deep passion for advancing holistic health and medical science rooted in ancient wisdom 🌿. With a strong foundation in both theoretical and practical aspects of Traditional Chinese Medicine, Prof. Yan continues to contribute significantly to research, education, and innovation in this timeless and evolving discipline 📚🔬.

Experience

Prof. Dan Yan 🌟 has actively served on numerous prestigious academic committees, showcasing he leadership in Traditional Chinese Medicine. Since 2023, he has been recognized as a National High-level Leading Talent 🇨🇳, Director of a Key Discipline under the National Administration of TCM 🏛️, and a recipient of the Chinese Government Special Allowance 🏅. He is also a member of the China National Pharmacopoeia Committee (2022–2027) 📘 and holds leadership roles in institutes focused on clinical pharmacy, precision medicine, and rational drug use 💊📊. He extensive contributions highlight he dedication to advancing science, policy, and international collaboration in healthcare 🌐🧬.

Research Focus

Prof. Dan Yan is a leading researcher in metabolic diseases, particularly focusing on type 2 diabetes, insulin resistance, and gut microbiota 🧫. He research integrates microbiome science, metabolomics, and traditional Chinese medicine🌿 to develop novel therapeutic strategies. He investigates microbial metabolites (e.g., succinate, L-citrulline) and their roles in modulating intestinal immunity🦠 and enhancing drug responses like metformin efficacy💊. He studies also include chemodynamic therapy, biomarker discovery, and machine learning-based screening in diabetes diagnostics 🤖. Prof. Yan’s contributions are reshaping how we understand and manage chronic metabolic disorders on a molecular and systemic level.

Publication Top Notes

Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis

Function, mechanism of action, metabolism, and commercial application of Lonicera japonica: a review

Coupling Probiotics with CaO2 Nanoparticle-Loaded CoFeCe-LDH Nanosheets to Remodel the Tumor Microenvironment for Precise Chemodynamic Therapy

Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity

Circulating metabolites difference in type 2 diabetes patients from regions: a cross-sectional study

Detecting key genes relative expression orderings as biomarkers for machine learning-based intelligent screening and analysis of type 2 diabetes mellitus

Advances in in vitro assessment models and screening methods for blood glucose-lowering medications

Discovery of the targets and lead compounds of traditional chinese medicine based on the molecular trajectory of diabetes evolution

3D spheroid HepaRG and fluorescent biphasic tracer for CYP3A4-mediated antibiotic interaction monitoring in sepsis

Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin

Dr. Sukhendu Dey |Pharmacology |Best Researcher Award

Posted on by sciencefather

Dr. Sukhendu Dey|Pharmacology|Best Researcher Award

Dr. Sukhendu Dey at The University of Burdwan,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Sukhendu Dey was born on April 2, 1992, in West Bengal, India. He embarked on his academic journey with a deep interest in environmental sciences, obtaining a Ph.D. in Environmental Science. His focus areas during his doctoral studies included aquatic toxicology, fish hematology, and the use of biomarkers in environmental risk assessments.

Prior to his Ph.D., Dr. Dey completed his M.Sc. in Environmental Science, where he graduated with first-class honors. His consistent academic excellence also extended to a Post Graduate Diploma in Disaster Management, equipping him with the skills to address complex environmental challenges. Additionally, he earned a B.Ed. in Life Sciences, emphasizing his interest in education and knowledge dissemination.

Professional Endeavors 🔬

Currently serving as a Technical Assistant Gr.-II at The University of Burdwan, West Bengal, Dr. Dey plays a pivotal role in facilitating research and managing technical aspects of the university’s environmental science department. His 8-year research career has been supplemented by teaching experiences, where he imparted his knowledge in environmental toxicology and ecological sciences.

Dr. Dey’s professional focus lies in various interconnected areas of biochemistry, aquatic toxicology, risk assessment, and environmental toxicology. His research primarily revolves around understanding the biochemical impacts of pollutants on aquatic ecosystems, contributing to the development of new strategies for environmental preservation and sustainability.

Contributions and Research Focus 📚

Dr. Dey’s research contributions are both extensive and impactful. He has published over 30 research articles, 31 book chapters, and edited 5 books. His work spans across topics like biomarkers in aquatic systems, toxicity analysis, and the ecological impacts of pollutants.

Some of his significant research contributions are in the field of:

  • Fish Hematology: Understanding the blood parameters in fish as indicators of environmental stress.
  • Biomarkers: Developing methods to assess the health of aquatic environments through biochemical markers.
  • Aquatic Toxicology: Investigating the effects of chemical pollutants on aquatic organisms and ecosystems.

His scholarly publications are available on Google Scholar, where his research has been well-cited by peers across various domains, signifying the importance of his work in the scientific community.

Accolades and Recognition 🏅

Dr. Dey’s hard work and dedication have been recognized on numerous occasions. He was awarded the Environmental Research Excellence Award 2023 at the 9th International Conference on Environment and Ecology, a prestigious honor celebrating his contributions to environmental research. This accolade is a testament to his relentless pursuit of understanding and mitigating environmental issues.

Additionally, Dr. Dey has been an integral part of several conferences and seminars. He has organized and contributed to international and national-level seminars, workshops, and training programs on topics ranging from environmental crises to cutting-edge research techniques.

Impact and Influence 🌱

Dr. Dey’s influence extends beyond his research publications. He has actively participated in initiatives aimed at environmental conservation and sustainability. As a technical assistant at The University of Burdwan, he has mentored young researchers and students, fostering a new generation of environmental scientists.

He has played a significant role in organizing key events, such as the International Conference on Mother Earth: Save It to Achieve a Sustainable Future for All and the DST-PURSE Sponsored International Conference on Frontiers in Biological Environment and Medical Sciences. These efforts have brought together scientists, policymakers, and environmental advocates to discuss sustainable solutions for global environmental challenges.

In addition to his contributions at academic institutions, Dr. Dey is involved with the NGO Friends of the Earth (FOE), where he holds a lifetime membership. His work with the NGO reflects his commitment to using his scientific expertise for community-based environmental initiatives.

Legacy and Future Contributions 🚀

As Dr. Sukhendu Dey continues to explore the frontiers of environmental science, his legacy is one of passion, dedication, and impact. His research in aquatic toxicology and environmental toxicology has paved the way for better understanding the environmental risks posed by pollutants.

Dr. Dey’s future contributions are expected to expand further into the realm of environmental sustainability and risk mitigation, focusing on creating safer ecosystems and reducing the impacts of industrial and environmental pollutants.

Moreover, his involvement in interdisciplinary workshops and seminars indicates his desire to bridge the gap between research and practical applications, ensuring that his work has both scientific and societal relevance.

Conclusion 🌿

Dr. Sukhendu Dey’s career reflects an unwavering dedication to environmental science and its application in safeguarding ecosystems. From his early academic achievements to his ongoing professional endeavors, he has consistently contributed to the field of environmental toxicology. His awards, publications, and role in academic institutions mark him as a thought leader in his field, whose research has both national and international implications.

As a rising figure in environmental science, Dr. Dey’s legacy will continue to inspire future generations, promoting sustainability and environmental stewardship for years to come.

🎓Publication 

Integrative assessment of biomarker responses in teleostean fishes exposed to glyphosate-based herbicide (Excel Mera 71)

  • Authors   : Sukhendu Dey, Palas Samanta, Sandipan Pal, Aloke Kumar Mukherjee, Debraj Kole, Apurba Ratan Ghosh
  • Journal    :Emerging Contaminants
  • Year         :2016

Valorization of wastewater: A paradigm shift towards circular bioeconomy and sustainability

  • Authors   : Debajyoti Kundu, Deblina Dutta, Palas Samanta, Sukhendu Dey, Knawang Chhunji Sherpa, Sunil Kumar, Brajesh Kumar Dube
  • Journal    :Science of the Total Environment
  • Year         :2022

Dose specific responses of Anabas testudineus (Bloch) to anthracene (PAH): Haematological and biochemical manifestation

  • Authors   : Sukhendu Dey, Palas Samanta, Niladri Sekhar Mondal, Debraj Kole, Arghya Mandal, Atanu Patra, Apurba Ratan Ghosh
  • Journal    :Emerging Contaminants
  • Year         :2019

Time-Dependent Naphthalene Toxicity in Anabas testudineus (Bloch): A Multiple Endpoint Biomarker Approach

  • Authors   : Sukhendu Dey, Puspita Ballav, Palas Samanta, Arghya Mandal, Atanu Patra, Subhas Das, Arnab Kumar Mondal, Apurba Ratan Ghosh
  • Journal    :ACS omega
  • Year         :2020

Prof. Anca Oana Hermenean |Pharmacology |Best Innovation Award

Posted on by sciencefather

Prof. Anca Oana Hermenean|Pharmacology |Best Innovation Award|

Prof. Anca Oana Hermenean at Vasile Goldis Western University of Arad, Romania

PROFILE  

scopus

Orcid

Early Academic Pursuits 📚

Prof. Dr. Anca Hermenean began her academic journey at Babes-Bolyai University of Cluj-Napoca, Romania, where she earned her Bachelor’s degree in Biology from 1989 to 1994. This foundational education set the stage for her extensive career in biochemistry and molecular biology. Her academic prowess continued to shine as she pursued a PhD in Biology from 1997 to 2003, focusing on electron microscopy, histopathology, and immunohistochemistry. This period of intense study was marked by rigorous research and a commitment to understanding the microscopic and molecular mechanisms underlying various biological processes.

Professional Endeavors 🏛️

Prof. Hermenean’s professional career is distinguished by her roles in academia and research management. Since 2010, she has served as a Professor at the Faculty of Medicine, Vasile Goldis Western University of Arad (VGWU), where she has made significant contributions to the fields of histology and cell biology. Her expertise in these areas is evidenced by her ongoing research and teaching responsibilities.

In 2016, Prof. Hermenean was appointed Director of the VGWU Doctoral Studies Council, a role in which she has overseen the management and strategic development of doctoral programs in Medicine and Biology. Her leadership extended further in 2017 when she joined the Faculty of Engineering in Foreign Languages at Politehnica University of Bucharest, contributing to the Master Program in Biomaterials for Tissue Engineering. She has taught various courses related to cell and tissue biology, tissue regeneration, and debilitating diseases of tissue.

In 2020, Prof. Hermenean became the Director of the Life Science Institute and Principal Investigator at the Institute of Life Sciences, VGWU. Here, she manages research projects and oversees activities in microscopy labs and the animal facility, reflecting her deep engagement in both research and administration.

Contributions and Research Focus 🔬

Prof. Hermenean’s research contributions are broad and impactful, focusing on several key areas:

  1. Histology and Histopathology: Her work in these fields explores the microscopic structure of tissues and the pathological changes associated with various diseases. This includes significant contributions to understanding how cellular and tissular alterations can affect health.
  2. Phytomedicine: Prof. Hermenean has researched the modulation of signal transduction pathways by phytochemicals, their molecular regulation of anti-inflammatory and anti-fibrotic responses, and their interactions with drugs and chemicals.
  3. Nanobiotechnology: She has been involved in the characterization of bio-interfaces and in vivo biocompatibility studies of nanomaterials. Her work includes assessing the interactions between nanomedicines and biological systems, as well as evaluating structural and ultrastructural toxicological effects.
  4. Regenerative Medicine: Prof. Hermenean’s research also covers tissue repair and regeneration pathways, focusing on molecular signals, growth factors, and the mechanisms of tissue regeneration.

Accolades and Recognition 🏆

Prof. Hermenean’s work has garnered significant recognition within the scientific community. She holds a habilitation in Biology, a postdoctoral qualification that allows her to supervise PhD candidates. Her research has led to numerous publications in peer-reviewed journals, with an H-index of 30 on Scopus and 34 on Google Scholar. Additionally, she has been awarded several patents for her innovations in pharmaceutical compositions and drug delivery systems, underscoring her contributions to practical and applied sciences.

Impact and Influence 🌍

Prof. Hermenean’s influence extends beyond her research and teaching. Her roles in managing research councils and institutes highlight her ability to shape research strategies and educational programs. Her contributions have had a tangible impact on the advancement of biomedical sciences, particularly in the fields of histology, nanobiotechnology, and regenerative medicine.

Her work on phytomedicine and nanobiotechnology is particularly notable for its potential applications in developing new therapeutic approaches and improving existing medical treatments. Her patents and research projects reflect her commitment to translating scientific discoveries into practical solutions.

Legacy and Future Contributions 🔮

Prof. Hermenean’s legacy is marked by her dedication to advancing scientific knowledge and training the next generation of researchers. Her leadership in establishing and managing research infrastructures, such as the animal facility and microscopy labs at VGWU, demonstrates her commitment to fostering a supportive environment for cutting-edge research.

Looking ahead, Prof. Hermenean is poised to continue making significant contributions to her fields of expertise. Her ongoing research and collaborations are expected to yield further advancements in phytomedicine, nanobiotechnology, and regenerative medicine. Her role as a mentor and educator will also play a crucial part in shaping future research and development in these areas.

🎓Publication 

Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver

  • Authors   :Balta, C., Herman, H., Ciceu, A., … D’Amico, M., Hermenean, A..
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice

  • Authors   :Wang, S., Yu, X., Cheng, L., … Lu, Y., Wu, X..
  • Journal    :Cell Death and Disease
  • Year         :2024

Exploring In Vivo Pulmonary and Splenic Toxicity Profiles of Silicon Quantum Dots in Mice

  • Authors   :Cristian, R.-E., Balta, C., Herman, H., … Dinischiotu, A., Stan, M.S..
  • Journal    :Materials.
  • Year         :2024

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system

Colloidal and Biological Characterization of Dual Drug-Loaded Smart Micellar Systems

  • Authors   :Herman, H., Rata, D.M., Cadinoiu, A.N., Atanase, L.I., Hermenean, A..
  • Journal    :Polymers
  • Year         :2024

Prof Dr. Elaine Leung|Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof Dr. Elaine Leung |Pharmacology|Best Researcher Award|

Prof Dr. Elaine Leung at Department of Biomedical Science, Faculty of Health Science, Macau

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Elaine Lai-Han Leung embarked on her academic journey with a strong foundation in biological sciences, obtaining her BSc in Biology and Biochemistry from The Chinese University of Hong Kong in 2001. Her deep interest in biomedical sciences led her to pursue further studies, earning an MPhil in Biochemistry in 2003, followed by a PhD in Physiology in 2006 from the same institution. Her early academic pursuits laid the groundwork for a career marked by significant contributions to biomedical research, particularly in the fields of cancer biology and traditional Chinese medicine.

Professional Endeavors 🧬

Professor Leung’s professional career has been centered at the University of Macau, where she is a prominent figure in the Department of Biomedical Science, Faculty of Health Science. Over the years, she has established herself as a leading researcher, focusing on the intersection of modern biomedical sciences and traditional Chinese medicine. Her work has involved both academic research and collaborations with industry, where she has taken on numerous consultancy projects, contributing to the development of new therapies and drug discoveries.

Contributions and Research Focus 🔬

Professor Leung’s research is primarily focused on cancer biology, with an emphasis on non-small cell lung cancer (NSCLC). She has been the principal investigator (PI) or co-investigator (Co-I) on numerous research projects, many of which are aimed at understanding the mechanisms of drug resistance and the development of novel therapeutic strategies. Her ongoing research includes studies on KRAS resistance mechanisms, the role of gut microbiota in cancer immunomodulation, and the use of traditional Chinese medicine in treating various forms of cancer.

Some of her key projects include:

  • The relationship between KRAS resistance mechanisms and the immune microenvironment: An ongoing project at the University of Macau aimed at uncovering how KRAS mutations affect immune responses in cancer.
  • High-dimensional single-cell analysis of Sotorasib resistance clinical samples: This research seeks to identify new small molecule inhibitors for treating NSCLC.
  • Investigation of the anti-tumor effect of microbial valeric acid in NSCLC: Completed in 2023, this study explored how microbial byproducts can influence tumor immunity.

Accolades and Recognition 🏆

Professor Leung’s contributions to biomedical science have not gone unnoticed. She has been recognized with numerous awards and honors throughout her career, reflecting her standing in the scientific community. Her work has been cited extensively in leading scientific journals, with her citation index reflecting her influence in the fields of cancer biology and traditional Chinese medicine. Her collaboration with Nobel Laureate Erwin Neher on drug research further underscores her prominence in the field.

Impact and Influence 🌍

The impact of Professor Leung’s work extends beyond academia. Her research has significant implications for the development of new cancer therapies, particularly in the context of drug resistance. By bridging the gap between traditional Chinese medicine and modern biomedical research, she has opened new avenues for treatment that could benefit patients worldwide. Her work on gut microbiota and its role in cancer treatment, for instance, is pioneering in its approach and has the potential to revolutionize how cancer is treated.

Legacy and Future Contributions 🌟

As Professor Leung continues her work at the University of Macau, her legacy is already taking shape. She is helping to mentor the next generation of scientists while pushing the boundaries of what is possible in cancer research. Her ongoing projects, including those funded by significant grants, are expected to yield new insights into cancer biology and treatment. Looking ahead, her contributions will likely continue to influence the field of biomedical sciences, particularly in how traditional Chinese medicine is integrated into modern therapeutic strategies.

Research and Innovations 🧪

Completed/Ongoing Research Projects 📊

Professor Leung has completed numerous research projects, with many others ongoing. Her portfolio includes more than a dozen major projects, ranging from small-scale studies to large, collaborative efforts with industry partners. These projects have attracted significant funding, including:

  • Macao Science and Technology Development Fund (2021/2024): Investigating the combinational treatment effects of ginseng polysaccharides with immunotherapy in lung cancer, with a budget of USD 230,769.
  • Zhuhai UM Science and Technology Institute joint lab projects: Ongoing studies on drug resistance and immune microenvironment interactions in cancer, funded at approximately USD 641,000.

Citation Index 📚

Professor Leung’s work is highly regarded in the scientific community, as reflected by her citation index in databases such as Scopus and the Science Citation Index (SCI). Her research articles have been cited extensively, demonstrating the impact and relevance of her work in advancing biomedical science.

Consultancy/Industry Projects 🤝

Beyond academia, Professor Leung has engaged in several industry-sponsored projects, often serving as a consultant. These projects have allowed her to apply her research in practical settings, contributing to the development of new drugs and therapeutic strategies. Notably, she has collaborated with leading pharmaceutical companies like Janssen Pharmaceuticals, where her work on immunophenotyping in lung cancer patients has been highly influential.

Conclusion 🎯

Professor Elaine Lai-Han Leung’s career is a testament to the power of interdisciplinary research and collaboration. Her contributions to cancer biology, her innovative use of traditional Chinese medicine, and her commitment to bridging the gap between research and industry have made her a pivotal figure in her field. As she continues to explore new frontiers in biomedical science, her legacy will undoubtedly be one of lasting impact, shaping the future of cancer treatment and beyond.

🎓Publication 

Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer

  • Authors   :Zhang, Y.-Z., Lai, H.-L., Huang, C., … Wu, Q.-B., Leung, E.L.-H.
  • Journal    :Phytomedicine
  • Year         :2024

Genome engineering of the human gut microbiome

MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis

  • Authors   :Peng, D., Li, J., Li, Y., … Yang, P., Li, G.
  • Journal    :Pharmacological Research.
  • Year         :2024

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis

 

Prof. Mohamed Abdelzaher|Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof. Mohamed Abdelzaher, Pharmacology,Best Researcher Award

Prof. Mohamed Abdelzaher, at Environmental Science and Industrial Development Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University,Egypt

PROFILE

scopus

Early Academic Pursuits 🎓

Mohamed Abuelseoud Abdelzaher embarked on his academic journey at Minia University, where he pursued a Bachelor of Science degree at the Faculty of Science. His passion for environmental science led him to further his studies, culminating in an MSc in Environmental Chemistry from the same institution. His master’s thesis focused on the physico-chemical properties of sewage sludge ash blended cement pastes, a topic that underscored his growing interest in sustainable construction materials. His academic pursuits did not stop there, as he later achieved a Ph.D. in Environmental Science and Industrial Development from the Faculty of Postgraduate Studies for Advanced Sciences at Beni-Suef University in 2019. His doctoral research delved into enhancing the physico-mechanical properties of white cement through the application of nanoparticles, highlighting his commitment to advancing materials science and its environmental implications.

Professional Endeavors 🏢

Dr. Abdelzaher’s professional career began in the industrial sector, where he worked as a Quality Control and Labs Manager at Italcementi Group, Helwan Cement Co., from 2005 to 2017. This role allowed him to gain substantial experience in quality assurance and environmental management within the cement industry. His work in this capacity was instrumental in ensuring that the company adhered to stringent environmental and quality standards, contributing to the sustainability of its operations.

In 2017, Dr. Abdelzaher transitioned into academia, taking on the role of Assistant Professor of Environmental Science and Industrial Development at Beni-Suef University’s Faculty of Postgraduate Studies for Advanced Sciences. In this role, he has been actively involved in teaching, research, and mentorship, guiding the next generation of environmental scientists and engineers. His professional journey reflects a seamless blend of industry experience and academic expertise, making him a respected figure in both fields.

Contributions and Research Focus 🔬

Dr. Abdelzaher’s research is primarily centered on the application of nanomaterials in construction materials and environmental science, with a particular emphasis on waste management. His work on enhancing the properties of white cement using nanoparticles is a testament to his innovative approach to solving environmental and industrial challenges. By integrating cutting-edge nanotechnology into traditional construction materials, he has contributed to the development of more durable and sustainable building solutions.

In addition to his research in construction materials, Dr. Abdelzaher has also made significant contributions to environmental science, particularly in the area of waste management. His work explores how waste materials can be repurposed and utilized in environmentally friendly ways, thereby reducing their impact on the environment and contributing to a circular economy.

Accolades and Recognition 🏅

Throughout his career, Dr. Abdelzaher has received numerous accolades and certifications that attest to his expertise and leadership in his field. He is a certified environmental specialist, having received recognition from the Egyptian Ministry of Environment. He also holds an MBA from Ain Shams University, which complements his scientific expertise with strong business acumen.

Dr. Abdelzaher’s leadership skills have been recognized on an international level, as evidenced by his fellowship from the Science Leadership Program in Africa. This fellowship highlights his role as a thought leader in environmental science, particularly in the context of developing nations. Additionally, he has been awarded fellowships for curriculum development and environmental management, further underscoring his contributions to academia and industry alike.

Impact and Influence 🌍

Dr. Abdelzaher’s work has had a profound impact on both the academic community and the industrial sector. His research on nanomaterials and waste management has influenced the development of more sustainable construction practices, contributing to the global push towards greener building solutions. His teachings and mentorship at Beni-Suef University have inspired countless students to pursue careers in environmental science, ensuring that his influence will be felt for generations to come.

Moreover, his involvement in various professional organizations and his role as a reviewer for environmental journals published by Elsevier demonstrate his commitment to advancing the field of environmental science. Through these roles, he has helped shape the direction of research and development in his field, ensuring that it continues to address the most pressing environmental challenges of our time.

Legacy and Future Contributions 🚀

As Dr. Abdelzaher continues his career, his legacy is one of innovation, leadership, and dedication to sustainability. His work in nanotechnology and waste management has laid the groundwork for future advancements in these fields, and his influence as an educator ensures that his knowledge and expertise will be passed on to the next generation of environmental scientists.

🎓Publication 

Effective impact of nano-plastic-waste incorporated with nanotitina on the physical, mechanical and microstructural properties of white cement pastes composites for progressing towards sustainability

  • Authors   :Abdelzaher, M.A., Farghali, A.A., Hamouda, A.S.
  • Journal    :Scientific Reports
  • Year         :2024

Production, characterization and performance of green geopolymer modified with industrial by-products

    • Authors :Abbas, R., Abdelzaher, M.A., Shehata, N., Tantawy, M.A.
    • Journal   :Scientific Report
    • Year       : 2024

Effect of ginger, chamomile, and green tea extracts on prostate cancer cells

Bacterial biodegradation of oil-contaminated soil for pollutant abatement contributing to achieve sustainable development goals: A comprehensive review

  • Authors  :Aziz, Z.S., Jazza, S.H., Dageem, H.N., … Balboul, B.A., Abdelzaher, M.A.
  • Journal   :Results in Engineering
  • Year        :   2024

Experimental and Theoretical Study of Water Amount on the Rheological Features of Marble Sludge Grout

Dr. Samer Younes| Pharmacology| Best Researcher Award-1225

Posted on by sciencefather

Dr. Samer Younes,Pharmacology ,Best Researcher Award

Dr. Samer Younes, at Tartous University, Syria

 Profile

Goole scholar

    

🎓Early Academic Pursuits :

Samer Younes began his academic journey with a strong focus on pharmaceutical sciences. His passion for the field was evident early on as he pursued a Bachelor’s degree in Pharmacy from the Faculty of Pharmacy at Tartous University, Syria. His dedication to his studies was unwavering, and he successfully completed his degree on January 31, 2024. This foundational education equipped him with extensive knowledge in clinical pharmacology and pharmaceutical services, setting the stage for his professional and academic endeavors.

💼Professional Endeavors :

Upon completing his degree, Samer Younes embarked on a professional career that quickly showcased his capabilities and commitment to the field. With two years of experience in pharmaceutical services, he demonstrated a compassionate and systematic approach to his work. His extensive background in clinical pharmacology and strong clinical and technical knowledge enabled him to deliver community health education programs effectively. Samer’s professional journey has been marked by a relentless pursuit of excellence and a desire to contribute significantly to the field of pharmacy.

🧪Contributions and Research Focus :

Samer Younes has made notable contributions to pharmaceutical research and innovation. His research endeavors have been diverse and impactful, with a focus on nutrition, nutrients, and pharmacology. He has completed or is currently engaged in 19 research projects, showcasing his dedication to advancing knowledge in his field. His work has been recognized and cited in relevant academic databases, reflecting the significance of his contributions to the scientific community. Samer’s research is characterized by its rigor and relevance, addressing critical issues in pharmacology and drug discovery.

🏆Accolades and Recognition :

Throughout his academic and professional journey, Samer Younes has received recognition for his outstanding contributions. His research has been published in reputable journals, and he has been involved in 19 consultancy or industry-sponsored projects. These achievements underscore his expertise and the high regard in which he is held within the pharmaceutical community. Although specific awards and honors have not been detailed, his professional and academic accomplishments speak volumes about his impact and influence in the field.

🌍Impact and Influence :

Samer Younes’s work has had a significant impact on both his immediate community and the broader field of pharmaceutical sciences. His involvement in community health education programs has helped raise awareness and improve public health outcomes. Additionally, his research contributions have advanced the understanding of various aspects of pharmacology, influencing both academic and practical applications. His commitment to sharing knowledge and improving healthcare practices highlights his role as a leader and innovator in the field.

🌟Legacy and Future Contributions :

Looking ahead, Samer Younes is poised to make even greater contributions to pharmaceutical sciences. His pursuit of full-funded scholarships for continuing his master’s degree studies indicates a commitment to furthering his education and research capabilities. With his solid academic background, professional experience, and ongoing research projects, Samer is well-positioned to leave a lasting legacy in the field. His future contributions are expected to drive innovation, enhance pharmaceutical practices, and inspire the next generation of pharmacists and researchers.

🎓Publication 

The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis

  • Authors   :Samer Younes
  • Journal    :Diabetes Epidemiology and Management
  • Year         : 2024

The role of nutrition on the treatment of Covid 19

    • Authors :Samer Younes
    • Journal   :Human Nutrition & Metabolism
    • Year       : 2024

The role of micronutrients on the treatment of diabetes

  • Authors  :Samer Younes
  • Journal    :Human Nutrition & Metabolism
  • Year         :  2024

The impact of micronutrients on the sense of taste

  • Authors  :Samer Younes
  • Journal   :Human Nutrition & Metabolism
  • Year        :   2023

A Comprehensive Examination of the Nutritional Sufficiency of Vegan Recipes Widely Available in the Market

  • Authors  :Samer Younes
  • Journal   :J. Nutrition and Food Processing
  • Year        :   2024